News

Top Stories

Latest News

  • September 22, 2016

    Seventy-five percent of patients with moderate to severe alopecia areata had significant hair regrowth after treatment with ruxolitinib, reported researchers from Columbia University Medical Center.

    Topic

    Dermatology